Citations

Showing 10 of 108152 citations.

The haemodynamic basis of lung congestion during exercise in heart failure with preserved ejection fraction
Reddy, Yogesh N.V. , Obokata, Masaru , Wiley, Brandon M. , Koepp, Katlyn E. , Jorgenson, Caitlin C., Egbe, Alexander C. , Melenovský, Vojtěch , Carter, Rickey E. , Fermoyle, Caitlin C. , Wiley, Brandon, Nishimura, Rick , Carter, Rickey E , Obokata, Masaru , Melenovský, Vojtěch , Borlaug, Barry A.

Mayo Clinic

European Heart Journal | October 8, 2019 | Volume: 40 | Issue: 45 | Pages: 3721-3730

10.1093/eurheartj/ehz713 | PMID 31609443 Get It

Abstract Aims Increases in extravascular lung water (EVLW) during exercise contribute to symptoms, morbidity, and mortality in patients with heart failure and preserved ejection fraction (HFpEF), but the mechanisms leading to pulmonary congestion during exercise are not well-understood. Methods and results Compensated, ambulatory patients with HFpEF (n = 61) underwent invasive haemodynamic exercise testing using high-fidelity micromanometers with simultaneous lung ultrasound, echocardiography, and expired gas analysis at rest and during submaximal exercise. The presence or absence of EVLW was determined by lung ultrasound to evaluate for sonographic B-line artefacts. An increase in EVLW during exercise was observed in 33 patients (HFpEFLW+, 54%), while 28 (46%) did not develop EVLW (HFpEFLW−). Resting left ventricular function was similar in the groups, but right ventricular (RV) dysfunction was two-fold more common in HFpEFLW+ (64 vs. 31%), with lower RV systolic velocity and RV fractional area change. As compared to HFpEFLW−, the HFpEFLW+ group displayed higher pulmonary capillary wedge pressure (PCWP), higher pulmonary artery (PA) pressures, worse RV-PA coupling, and higher right atrial (RA) pressures during exercise, with increased haemoconcentration indicating greater loss of water from the vascular space. The development of lung congestion during exercise was significantly associated with elevations in PCWP and RA pressure as well as impairments in RV-PA coupling (area under the curve values 0.76–0.84). Conclusion Over half of stable outpatients with HFpEF develop increases in interstitial lung water, even during submaximal exercise. The acute development of lung congestion is correlated with increases in pulmonary capillary hydrostatic pressure that favours fluid filtration, and systemic venous hypertension due to altered RV-PA coupling, which may interfere with fluid clearance. Clinical trial registration NCT02885636.
Deep Learning for Automating the Organization of Institutional Dermatology Image Stores
Wang, Michael Z. , Comfere, Nneka I. , Murphree, Dennis H.

Mayo Clinic

2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) | October 8, 2019 | Volume: No volume available | Issue: No issue available | Pages: 4479-4482

10.1109/embc.2019.8857086 | PMID 31946860 Get It

Feasibility of High-Resolution Electrical Mapping for Characterizing Conduction Blocks Created by Gastric Ablation
Aghababaie, Zahra , Chan, Chih-Hsiang Alexander , Farrugia, Gianrico , Asirvatham, Samuel J. , O’Grady, Gregory , Cheng, Leo K. , Angeli, Timothy R. , Asirvatham, Samuel J , Angeli-Gordon, Timothy R , Paskaranandavadivel, Niranchan , Beyder, Arthur

Mayo Clinic

2019 41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) | October 7, 2019 | Volume: No volume available | Issue: No issue available | Pages: 170-173

10.1109/embc.2019.8856406 | PMID 31945871 Get It

NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Kumar, Shaji , Hillengaß, Jens , Liedtke, Michaela , Campagnaro, Erica , Chandler, Jason C., Cornell, Robert F. , Costello, Caitlin , Efebera, Yvonne A. , Faiman, Matthew , Garfall, Alfred L. , Godby, Kelly, Holmberg, Leona , Htut, Myo , Huff, Carol Ann , Malek, Ehsan , Omel, James, Sborov, Douglas W. , Stockerl‐Goldstein, Keith , Tan, Carlyn , Weber, Donna, Johnson-Chilla, Alyse, Keller, Jennifer , Holmberg, Leona , Callander, Natalie S. , Baljević, Muhamed , Castillo, Jorge J. , Kang, Yubin , Landgren, Ola , Martin, Thomas G. , Raje, Noopur , Singhal, Seema , Kumar, Rashmi , Garfall, Alfred L , Campagnaro, Erica L , Stockerl-Goldstein, Keith

Mayo Clinic

Journal of the National Comprehensive Cancer Network | October 7, 2019 | Volume: 17 | Issue: 10 | Pages: 1154-1165

10.6004/jnccn.2019.0049 | PMID 31590151 Get It

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates and changes in the 1.2020 version of the NCCN Guidelines for Multiple Myeloma.
High GILT Expression and an Active and Intact MHC Class II Antigen Presentation Pathway Are Associated with Improved Survival in Melanoma
Buetow, Kenneth H. , Meador, Lydia R., Menon, Hari , Lu, Yih‐Kuang, Brill, Jacob, Cui, Haiyan , Roe, Denise J. , DiCaudo, David J. , Hastings, Karen Taraszka , Hastings, K Taraszka

Mayo Clinic

The Journal of Immunology | October 7, 2019 | Volume: 203 | Issue: 10 | Pages: 2577-2587

10.4049/jimmunol.1900476 | PMID 31591149 Get It

Abstract The MHC class I Ag presentation pathway in melanoma cells has a well-established role in immune-mediated destruction of tumors. However, the clinical significance of the MHC class II Ag presentation pathway in melanoma cells is less clear. In Ag-presenting cells, IFN-γ–inducible lysosomal thiol reductase (GILT) is critical for MHC class II–restricted presentation of multiple melanoma Ags. Although not expressed in benign melanocytes of nevi, GILT and MHC class II expression is induced in malignant melanocytes in a portion of melanoma specimens. Analysis of The Cancer Genome Atlas cutaneous melanoma data set showed that high GILT mRNA expression was associated with improved overall survival. Expression of IFN-γ, TNF-α, and IL-1β was positively associated with GILT expression in melanoma specimens. These cytokines were capable of inducing GILT expression in human melanoma cells in vitro. GILT protein expression in melanocytes was induced in halo nevi, which are nevi undergoing immune-mediated regression, and is consistent with the association of GILT expression with improved survival in melanoma. To explore potential mechanisms of GILT’s association with patient outcome, we investigated pathways related to GILT function and expression. In contrast to healthy skin specimens, in which the MHC class II pathway was nearly uniformly expressed and intact, there was substantial variation in the MHC class II pathway in the The Cancer Genome Atlas melanoma specimens. Both an active and intact MHC class II pathway were associated with improved overall survival in melanoma. These studies support a role for GILT and the MHC class II Ag presentation pathway in melanoma outcome.
Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis
Kato, Nahoko , Padang, Ratnasari , Pislaru, Cristina , Miranda, William R. , Hoshina, Mizuho, Shibayama, Kentaro , Watanabe, Hiroyuki , Greason, Kevin L. , Pislaru, Sorin V. , Pellikka, Patricia A. , Sabbah, Michael S. , Pellikka, Patricia A , Pislaru, Cristina , Scott, Christopher G. , Nkomo, Vuyisile T.

Mayo Clinic

Circulation | October 7, 2019 | Volume: 140 | Issue: 15 | Pages: 1251-1260

10.1161/circulationaha.119.040679 | PMID 31589485 Get It

Background: Mitral stenosis frequently coexists in patients with severe aortic stenosis. Mitral stenosis severity evaluation is challenging in the setting of combined aortic stenosis and mitral stenosis because of hemodynamic interactions between the 2 valve lesions. The impact of aortic valve replacement (AVR) for severe aortic stenosis on mitral stenosis is unknown. This study aimed to assess the effect of AVR on mitral stenosis hemodynamics and the clinical outcomes of patients with severe aortic stenosis with and without mitral stenosis. Methods: We retrospectively investigated patients who underwent surgical AVR or transcatheter AVR for severe aortic stenosis from 2008 to 2015. Mean transmitral gradient by Doppler echocardiography ≥4 mm Hg was identified as mitral stenosis; patients were then stratified according to mitral valve area (MVA, by continuity equation) as >2.0 cm 2 or ≤2.0 cm 2 . MVA before and after AVR in patients with mitral stenosis were evaluated. Clinical outcomes of patients with and without mitral stenosis were compared using 1:2 matching for age, sex, left ventricular ejection fraction, method of AVR (surgical AVR versus transcatheter AVR) and year of AVR. Results: Of 190 patients with severe aortic stenosis and mitral stenosis (age 76±9 years, 42% men), 184 were matched with 362 with severe aortic stenosis without mitral stenosis. Among all mitral stenosis patients, the mean MVA increased after AVR by 0.26±0.59 cm 2 (from 2.00±0.50 to 2.26±0.62 cm 2 , P <0.01). MVA increased in 105 (55%) and remained unchanged in 34 (18%). Indexed stroke volume ≤45 mL/m 2 (odds ratio [OR] 2.40; 95% CI, 1.15–5.01; P =0.020) and transcatheter AVR (OR, 2.36; 95% CI, 1.17–4.77; P =0.017) were independently associated with increase in MVA. Of 107 with significant mitral stenosis (MVA ≤2.0 cm 2 ), MVA increased to >2.0 cm 2 after AVR in 52 (49%, pseudo mitral stenosis) and remained ≤2.0 cm 2 in 55 (51%, true mitral stenosis). During follow-up of median 2.9 (0.7–4.9) years, true mitral stenosis was an independent predictor of all-cause mortality (adjusted hazard ratio, 1.88; 95% CI, 1.20–2.94; P <0.01). Conclusions: MVA improved after AVR in nearly half of patients with severe aortic stenosis and mitral stenosis. MVA remained ≤2.0 cm 2 (true mitral stenosis) in nearly half of patients with severe aortic stenosis and significant mitral stenosis; this was associated with worse survival among patients undergoing AVR for severe aortic stenosis.
Sinonasal mucosal vasculature in yellow nail syndrome and chronic rhinosinusitis with or without polyps
Chatzopoulos, Kyriakos , Gutierrez, Claudia N. , García, Joaquín J. , Stokken, Janalee K., O’Brien, Erin K. , Choby, Garret , O'Brien, Erin K , Choby, Garret

Mayo Clinic

International Forum of Allergy & Rhinology | October 7, 2019 | Volume: 10 | Issue: 1 | Pages: 128-132

10.1002/alr.22446 | PMID 31589812 Get It

BackgroundLymphatic dysfunction is hypothesized to be an underlying factor in the pathophysiology of yellow nail syndrome (YNS) (yellow nails, lymphedema, pleural effusions, and frequently chronic rhinosinusitis [CRS]). It is unclear why some YNS patients develop CRS. We quantified lymphatic and total vasculature of sinonasal mucosa in YNS patients and compared it to controls from CRS patients with (CRSwNP) or without polyps (CRSsNP).MethodsImmunohistochemistry was performed on archival sinonasal mucosal samples from 5 patients with YNS and 14 controls with antibodies against podoplanin and CD31, markers of lymphatics. Morphometric assessment was performed on digital images using ImageJ software.ResultsIn YNS, the number of lymphatics/mm2 ranged from 7 to 18/mm2 (controls: 6 to 43/mm2, p = 0.343), with a mean perimeter between 92 and 201 µm (controls: 42 to 280 µm, p = 0.482). Total vasculature density was higher than lymphatics, ranging between 189 and 1159 vessels/mm2, average 669 (controls: 139 to 1467/mm2, average 503, p = 0.257) with smaller average perimeter, 40 to 117 µm, mean 64.8 µm (controls: 42 to 92 µm, mean 65.3 µm, p = 0.965). Lymphatics constituted only a small fragment of the total vasculature, ranging from 1.15% to 4.76%, average 2.34% (controls: 0.81% to 10.58%, average 4.88%, p = 0.156). CRSwNP patients had significantly higher lymphatic density (p = 0.011) and ratio of lymphatics to total vasculature (p = 0.045) than patients with YNS or CRSsNP.ConclusionThis is the first histological analysis of sinus mucosa in patients with YNS. Vascular type, density, size, and distribution in the sinonasal mucosa of YNS patients are not statistically significantly different from those of the CRSsNP group. Lymphatic density and ratio to total vasculature is higher in CRSwNP patients.
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, Michelle B., Donovan, Kristine A. , Andersen, Barbara L. , Braun, IIana, Breitbart, William , Brewer, Benjamin W. , Buchmann, Luke, Clark, Matthew M. , Collins, Molly, Corbett, Cheyenne , Fleishman, Stewart B., Garcia, Sofia F. , Greenberg, Donna, Handzo, Rev. George F., Hoofring, Laura, Huang, Chao‐Hui , Martin, Sara , McGuffey, Lisa, Mitchell, William M. , Morrison, Laura , Pailler, Megan E. , Parnes, Francine, Pazar, Janice P., Ralston, Laurel, Salman, Jaroslava, Shannon-Dudley, Moreen, Valentine, Alan , McMillian, Nicole R., Darlow, Susan, Garcia, Sofia F , Handzo, Rev. George F., Lally, Robin Mary , Mitchell, William, Palesh, Oxana Gronskaya

Mayo Clinic

Journal of the National Comprehensive Cancer Network | October 7, 2019 | Volume: 17 | Issue: 10 | Pages: 1229-1249

10.6004/jnccn.2019.0048 | PMID 31590149 Get It

Distress is defined in the NCCN Guidelines for Distress Management as a multifactorial, unpleasant experience of a psychologic (ie, cognitive, behavioral, emotional), social, spiritual, and/or physical nature that may interfere with the ability to cope effectively with cancer, its physical symptoms, and its treatment. Early evaluation and screening for distress leads to early and timely management of psychologic distress, which in turn improves medical management. The panel for the Distress Management Guidelines recently added a new principles section including guidance on implementation of standards of psychosocial care for patients with cancer.
Aligning Care With Patient Values and Priorities
Hargraves, Ian , Hargraves, Ian G, Montori, Víctor M.

Mayo Clinic

JAMA Internal Medicine | October 7, 2019 | Volume: 179 | Issue: 12 | Pages: 1697

10.1001/jamainternmed.2019.4230 | PMID 31589248 Get It

An Elderly Bias, Nocturia, and Adverse Effects of Sedative-Hypnotic Medication—Reply
Cho, Hyung J. , Morgenthaler, Timothy, Soong, Christine , Morgenthaler, Timothy I.

Mayo Clinic

JAMA Internal Medicine | October 7, 2019 | Volume: 179 | Issue: 10 | Pages: 1444

10.1001/jamainternmed.2019.4033 | PMID 31589267 Get It